Published in Law and Health Weekly, May 1st, 2004
Ciphergen and its collaborators reported that different diseases generate unique host responses that can be distinguished by the quantitative detection of disease-specific protein fragments, potentially opening up a novel approach to multi-biomarker diagnostics. Ciphergen has applied for patents on this...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law and Health Weekly